• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

永久性角膜移植术后的玻璃体视网膜手术。

Vitreoretinal surgery in the setting of permanent keratoprosthesis.

作者信息

Kiang Lee, Sippel Kimberly C, Starr Christopher E, Ciralsky Jessica, Rosenblatt Mark I, Radcliffe Nathan M, D'Amico Donald J, Kiss Szilárd

机构信息

Weill Cornell Medical College, Rockefeller University/Sloan-Kettering Institute Tri-Institutional MD-PhD Program, New York, NY 10021, USA.

出版信息

Arch Ophthalmol. 2012 Apr;130(4):487-92. doi: 10.1001/archophthalmol.2011.1115.

DOI:10.1001/archophthalmol.2011.1115
PMID:22491917
Abstract

OBJECTIVES

To evaluate the surgical management of vitreoretinal pathology in patients with a permanent Boston Type 1 keratoprosthesis (hereafter referred to as a KPro) in the era of small-gauge vitrectomy techniques.

METHODS

Retrospective review of 23 small-gauge vitreoretinal surgical procedures during or after Dohlman-Doane KPro placement in 14 eyes.

RESULTS

Established and innovative techniques were used, including sutureless small-gauge vitrectomy, temporal positioning of surgeon, long-term tamponades, and exploratory endoscopy. Retro-KPro membranes formed less frequently when vitrectomy was performed during KPro placement. Anatomical goals were achieved, and no serious complications directly resulted from these techniques. Visual acuity, frequently limited by preexisting pathology, improved in most cases.

CONCLUSIONS

Modern posterior segment surgical techniques, including small-gauge sutureless vitrectomy, can be effectively used for patients with a permanent KPro. Vitrectomy and glaucoma tube revision by a team of subspecialists at the time of KPro placement may reduce subsequent complications.

摘要

目的

评估在小切口玻璃体切割技术时代,永久性波士顿1型人工角膜(以下简称KPro)患者玻璃体视网膜病变的手术治疗方法。

方法

回顾性分析14只眼在植入多尔曼-多恩KPro期间或之后进行的23例小切口玻璃体视网膜手术。

结果

采用了成熟和创新的技术,包括无缝合小切口玻璃体切割术、术者颞侧定位、长期填塞和探索性内窥镜检查。在植入KPro期间进行玻璃体切割术时,KPro后膜形成的频率较低。实现了解剖学目标,这些技术未直接导致严重并发症。视力通常受原有病变限制,大多数病例有所改善。

结论

现代后段手术技术,包括小切口无缝合玻璃体切割术,可有效用于永久性KPro患者。在植入KPro时由专科医生团队进行玻璃体切割术和青光眼引流管修复术可能会减少后续并发症。

相似文献

1
Vitreoretinal surgery in the setting of permanent keratoprosthesis.永久性角膜移植术后的玻璃体视网膜手术。
Arch Ophthalmol. 2012 Apr;130(4):487-92. doi: 10.1001/archophthalmol.2011.1115.
2
Management of vitreoretinal complications in eyes with permanent keratoprosthesis.永久性角膜移植术后眼玻璃体视网膜并发症的处理
Arch Ophthalmol. 2002 May;120(5):559-66. doi: 10.1001/archopht.120.5.559.
3
Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.波士顿Ⅰ型角膜镜联合硅油治疗前期眼球低眼压。
Cornea. 2011 Oct;30(10):1105-9. doi: 10.1097/ICO.0b013e318207f3bb.
4
Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.与波士顿角膜假体 1 型和青光眼引流装置相关的并发症。
Br J Ophthalmol. 2013 May;97(5):573-7. doi: 10.1136/bjophthalmol-2012-302770. Epub 2013 Feb 23.
5
Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia.I 型波士顿角膜成形术治疗先天性无虹膜症的虹膜纤维变性综合征的手术和视觉效果。
Am J Ophthalmol. 2012 May;153(5):967-971.e2. doi: 10.1016/j.ajo.2011.10.027. Epub 2012 Jan 21.
6
Comparison of clear corneal phacoemulsification combined with 25-gauge transconjunctival sutureless vitrectomy and standard 20-gauge vitrectomy for patients with cataract and vitreoretinal diseases.比较超声乳化白内障吸除术联合 25G 经结膜无缝线玻璃体切割术与标准 20G 玻璃体切割术治疗白内障合并眼后段疾病的效果。
J Cataract Refract Surg. 2005 Jun;31(6):1198-207. doi: 10.1016/j.jcrs.2004.11.041.
7
Wide-field vitreoretinal surgery in eyes with Boston type 1 keratoprosthesis.广角玻璃体视网膜手术在波士顿 1 型角膜镜植入眼中的应用。
Int Ophthalmol. 2022 Mar;42(3):997-1005. doi: 10.1007/s10792-021-02083-7. Epub 2021 Oct 12.
8
Safety of 20-gauge transconjunctival sutureless vitrectomy.20 号经结膜无缝线玻璃体切除术的安全性。
Ophthalmologica. 2013;230(4):207-14. doi: 10.1159/000346393. Epub 2013 Sep 12.
9
Pars plana vitrectomy through the Boston Keratoprosthesis type 1.经 Boston 角膜假体 1 型行板层玻璃体切除术。
Eye (Lond). 2013 Jun;27(6):767-9. doi: 10.1038/eye.2013.58. Epub 2013 Apr 12.
10
Keratoprosthesis: current techniques.角膜移植术:当前技术
Cornea. 2006 Jul;25(6):656-62. doi: 10.1097/01.ico.0000214226.36485.d2.

引用本文的文献

1
Outcomes of Boston Keratoprosthesis Type I Implantation in Poland: A Retrospective Study on 118 Patients.波兰I型波士顿人工角膜植入术的治疗效果:一项针对118例患者的回顾性研究
J Clin Med. 2024 Feb 8;13(4):975. doi: 10.3390/jcm13040975.
2
Boston Type 1 Keratoprosthesis: Updated Perspectives.波士顿1型人工角膜:最新观点
Clin Ophthalmol. 2020 Apr 29;14:1189-1200. doi: 10.2147/OPTH.S219270. eCollection 2020.
3
Simultaneous Vitreoretinal Surgery and Penetrating Keratoplasty without a Keratoprosthesis or Endoscopy for Vitreoretinal Disease Associated with Corneal Opacity.
对于伴有角膜混浊的玻璃体视网膜疾病,在不使用角膜假体或内镜的情况下同时进行玻璃体视网膜手术和穿透性角膜移植术。
Case Rep Ophthalmol. 2020 Mar 19;11(1):127-136. doi: 10.1159/000506589. eCollection 2020 Jan-Apr.
4
COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY.行单纯型波士顿角膜角膜镜植入术眼与联合巩膜平坦部玻璃体切除术眼的视觉和解剖学结果比较。
Retina. 2018 Sep;38 Suppl 1(Suppl 1):S125-S133. doi: 10.1097/IAE.0000000000002036.
5
Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes.波士顿人工角膜植入术后视网膜脱离:发病率、诱发因素及视觉预后
Digit J Ophthalmol. 2015 Dec 21;21(4):1-15. doi: 10.5693/djo.01.2015.10.001. eCollection 2015.
6
Boston type 1 keratoprosthesis from patient selection through postoperative management: a review for the keratoprosthetic surgeon.从患者选择到术后管理的波士顿1型人工角膜:给人工角膜外科医生的综述
Clin Ophthalmol. 2016 Mar 14;10:437-43. doi: 10.2147/OPTH.S83677. eCollection 2016.
7
A novel murine model for keratoprosthesis.一种新型角膜假体的小鼠模型。
Invest Ophthalmol Vis Sci. 2014 May 15;55(6):3681-5. doi: 10.1167/iovs.14-14058.